aporphine has been researched along with laurolitsine in 1 studies
| Studies (aporphine) | Trials (aporphine) | Recent Studies (post-2010) (aporphine) | Studies (laurolitsine) | Trials (laurolitsine) | Recent Studies (post-2010) (laurolitsine) |
|---|---|---|---|---|---|
| 86 | 0 | 47 | 10 | 0 | 4 |
| Protein | Taxonomy | aporphine (IC50) | laurolitsine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 2.5 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 6.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YL; Hsueh, CM; Ko, FN; Lee, SS; Liu, KC; Teng, CM | 1 |
1 other study(ies) available for aporphine and laurolitsine
| Article | Year |
|---|---|
Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Aporphines; Arachidonic Acid; Blood Platelets; Collagen; Cyclic AMP; Guaiacol; Humans; Isoquinolines; Isotope Labeling; Lipoxygenase Inhibitors; Male; Phenanthrenes; Platelet Activating Factor; Platelet Aggregation Inhibitors; Quinolines; Rabbits; Radioimmunoassay; Structure-Activity Relationship; Thrombin; Thromboxane B2; Vasoconstrictor Agents | 1997 |